Insider Transactions in Q1 2021 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2021
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-0.67%
|
$3,915
$9.59 P/Share
|
|
Mar 22
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,682
-0.92%
|
$76,820
$10.29 P/Share
|
|
Mar 15
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.56%
|
$220,000
$10.77 P/Share
|
|
Mar 15
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.5%
|
$132,000
$6.45 P/Share
|
|
Mar 05
2021
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,664
-1.69%
|
$46,640
$10.48 P/Share
|
|
Mar 05
2021
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,628
+5.68%
|
$33,256
$2.94 P/Share
|
|
Mar 01
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.37%
|
$18,000
$12.4 P/Share
|
|
Mar 01
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-2.7%
|
$115,654
$11.84 P/Share
|
|
Mar 01
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,514
+2.63%
|
$63,084
$6.45 P/Share
|
|
Mar 01
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.89%
|
$82,500
$11.85 P/Share
|
|
Feb 22
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,682
-0.9%
|
$84,502
$11.98 P/Share
|
|
Feb 16
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.52%
|
$264,000
$12.26 P/Share
|
|
Feb 16
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.46%
|
$132,000
$6.45 P/Share
|
|
Feb 01
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-2.7%
|
$199,766
$19.08 P/Share
|
|
Feb 01
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,514
+2.63%
|
$63,084
$6.45 P/Share
|
|
Feb 01
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.87%
|
$142,500
$19.08 P/Share
|
|
Feb 01
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.49%
|
$28,500
$19.09 P/Share
|
|
Jan 20
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
50,000
-5.5%
|
$1,050,000
$21.51 P/Share
|
|
Jan 15
2021
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,463
-3.68%
|
$303,723
$21.84 P/Share
|
|
Jan 15
2021
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,367
+6.95%
|
-
|
|
Jan 15
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.36%
|
$484,000
$22.24 P/Share
|
|
Jan 15
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.31%
|
$132,000
$6.45 P/Share
|
|
Jan 15
2021
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
31,608
-3.36%
|
$663,768
$21.84 P/Share
|
|
Jan 15
2021
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
80,327
+7.87%
|
-
|
|
Jan 15
2021
|
Hung Do Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,960
-2.27%
|
$209,160
$21.84 P/Share
|
|
Jan 15
2021
|
Hung Do Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,458
+4.88%
|
-
|
|
Jan 15
2021
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,770
-1.81%
|
$100,170
$21.84 P/Share
|
|
Jan 15
2021
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,502
+3.47%
|
-
|
|
Jan 15
2021
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,794
-3.83%
|
$184,674
$21.84 P/Share
|
|
Jan 15
2021
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,731
+8.28%
|
-
|
|
Jan 04
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.62%
|
$34,500
$23.17 P/Share
|
|
Jan 04
2021
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,369
+14.8%
|
-
|
|
Jan 04
2021
|
Samantha Prout Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,533
+28.63%
|
-
|
|
Jan 04
2021
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
57,620
+13.67%
|
-
|
|
Jan 04
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-3.32%
|
$231,308
$22.17 P/Share
|
|
Jan 04
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,514
+3.21%
|
$63,084
$6.45 P/Share
|
|
Jan 04
2021
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,131
+11.51%
|
-
|
|
Jan 04
2021
|
Hung Do Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,572
+7.68%
|
-
|
|
Jan 04
2021
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,131
+13.7%
|
-
|
|
Jan 04
2021
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
115,240
+11.81%
|
-
|
|
Jan 04
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-1.0%
|
$165,000
$22.17 P/Share
|
|
Jan 03
2021
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,974
-4.36%
|
$321,402
$23.09 P/Share
|
|
Jan 03
2021
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,053
-2.23%
|
$116,219
$23.09 P/Share
|
|
Jan 03
2021
|
Hung Do Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,938
-2.29%
|
$205,574
$23.09 P/Share
|
|
Jan 03
2021
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,306
-4.52%
|
$191,038
$23.09 P/Share
|
|
Jan 03
2021
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
19,994
-2.59%
|
$459,862
$23.09 P/Share
|
|
Jan 02
2021
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,974
-7.78%
|
$252,402
$23.09 P/Share
|
|
Jan 02
2021
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,413
-8.25%
|
$32,499
$23.09 P/Share
|
|
Jan 02
2021
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,908
-7.75%
|
$618,884
$23.09 P/Share
|
|
Jan 02
2021
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,164
-6.27%
|
$348,772
$23.09 P/Share
|